doi: 10.1007/BF02867955.
Characterisation of the canine cardiac sarcolemma in experimental myocardial ischemia
Affiliations
- PMID: 23100863
- PMCID: PMC3454035
- DOI: 10.1007/BF02867955
Item in Clipboard
Characterisation of the canine cardiac sarcolemma in experimental myocardial ischemia
Indian J Clin Biochem.
1997 Dec.
Abstract
The cardiac sarcolemma was characterized in 13 normal and 11 ischemic dog hearts by enzyme analysis and compositional assays. Significant decreases in the activities of the sodium-potassium and calcium pumps and structural compositional disturbances were observed in ischemia. High concentrations of oleic acid, a fatty acid and palmitoyl carnitine, a fatty acid intermediate caused inhibition of the enzyme pump activities of the normal sarcolemma. Thus, ischemia results in the functional impairment of the sarcolemma. Accumulation of fatty acid and fatty acid intermediates, occurring in myocardial ischemia, could be an underlying mechanism.
Keywords: Myocardial ischaemia; canine cardiac sarcolemma.
Similar articles
-
Effects of fatty acid intermediates on Na+-K+-ATPase activity of cardiac sarcolemma.Am J Physiol. 1982 Mar;242(3):H456-61. doi: 10.1152/ajpheart.1982.242.3.H456. Am J Physiol. 1982. PMID: 6278956
-
The effect of lipid intermediates on Ca2+ and Na+ permeability and (Na+ + K+)-ATPase of cardiac sarcolemma. A possible role in myocardial ischemia.Biochim Biophys Acta. 1984 Jul 11;774(1):127-37. doi: 10.1016/0005-2736(84)90283-9. Biochim Biophys Acta. 1984. PMID: 6329291
-
On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischaemia.Cardiovasc Res. 1987 May;21(5):313-22. doi: 10.1093/cvr/21.5.313. Cardiovasc Res. 1987. PMID: 3652098
-
Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart.J Cardiovasc Electrophysiol. 1993 Jun;4(3):288-310. doi: 10.1111/j.1540-8167.1993.tb01232.x. J Cardiovasc Electrophysiol. 1993. PMID: 8269301 Review.
-
Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis.Herz. 1995 Jun;20(3):156-68. Herz. 1995. PMID: 7543431 Review.
Cited by
-
Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.Br J Pharmacol. 2016 Oct;173(20):2966-91. doi: 10.1111/bph.13552. Epub 2016 Sep 9. Br J Pharmacol. 2016. PMID: 27439627 Free PMC article. Review.
-
Interplay of cholesterol, membrane bilayers and the AT1R: A cholesterol consensus motif on AT1R is revealed.Comput Struct Biotechnol J. 2020 Dec 3;19:110-120. doi: 10.1016/j.csbj.2020.11.042. eCollection 2021. Comput Struct Biotechnol J. 2020. PMID: 33384858 Free PMC article.
-
The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartan.Biochim Biophys Acta. 2014 Oct;1838(10):2439-50. doi: 10.1016/j.bbamem.2014.06.003. Epub 2014 Jun 16. Biochim Biophys Acta. 2014. PMID: 24946142 Free PMC article.
References
-
- Fleckenstein A., Janke J., Doring H.J., Pachinger O. Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions. Rec. Adv. Stud. Card. Met. 1973;2:455–466. - PubMed
-
- Daly M.J., Elz J.S., Nayler W.G. Sarcolemma enzymes and Na+—Ca2+ exchange in hypoxic, ischemic and reperfused rat hearts. Am. J. Physiol. 1984;247:4237–4243. - PubMed
-
- Katz A.M., Messineo F.C. Lipid-membrane interations and pathogenesis of ischemic damage in the myocardium. Circ. Res. 1981;48:1–16. - PubMed
-
- Chien K.R., Reeves J.P., Buja L.M., Bonte F., Parkey R.W., Willerson J.T. Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-ppi accumulation and an in vitro sarcolemmal Ca2+ permeability defect. Circ. Res. 1981;48:711–718. - PubMed
LinkOut - more resources
Full Text Sources